DN
Denali Therapeutics Inc.
DNLI · Denali Therapeutics Inc. · Healthcare
Up next day
5/12
42%
Fell despite growth
3/12
Good earnings ignored
Avg earnings move
±5.1%
typical swing on earnings
Price when beating
-3.0%
avg over 8 beats
Biggest single move
-13.4%
'23.12 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Tends to run up in the week before earnings
Rose beforehand 8 of last 12 · avg +2.7% · expectations build early
Even strong results barely move the stock
Up the next day 2 of 8 beats (25%)
Reaction is erratic and hard to predict
Avg -3.0% on a beat, +0.4% on a miss
Tends to keep drifting the same way for days
Day-one direction continued · 58% of last 12
vs Healthcare sector avg (153 peers)
This
-1.9%
Sector
+0.5%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
This stock reacts more to guidance & expectations than the reported number
Moved opposite to results 9 of last 12 times (75%)
6xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 5After close
'26.9 expectedEst. EPS $-0.41
Quarter ended 6/2026
Reported 2026-08-06
Next-day move
+0.4%
After 5 days +0.4%
vs Consensus$-0.47→$-0.68-45.5% miss
EPS
$-0.68
YoY +6%
Revenue
$0.0B
Next-Q guidance
—
N/A
Price around earnings
+21% run-up before
Earnings trend · last 12 quarters
EPS$-0.68YoY +6%
'23.9'26.6
Revenue$0.0B
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
2x17%
Met expectations
good · up ↑
3x25%
Disappointment
weak · down ↓
4x33%
Good earnings ignored
good · down ↓
3x25%
← ← Weak earningsStrong earnings → →
Weak earnings, price down — reacts honestly to earnings · 4 of 12q (33%)
Community · DNLI
What do you think of this stock's earnings pattern?
···